Conmed Corp (CNMD)
67.51
+0.47
(+0.70%)
USD |
NYSE |
Jul 03, 16:00
Conmed Research and Development Expense (Annual): 52.60M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 52.60M |
| December 31, 2022 | 47.15M |
| December 31, 2021 | 43.56M |
| December 31, 2020 | 40.47M |
| December 31, 2019 | 45.46M |
| December 31, 2018 | 42.19M |
| December 31, 2017 | 32.31M |
| December 31, 2016 | 32.25M |
| December 31, 2015 | 27.44M |
| December 31, 2014 | 27.78M |
| December 31, 2013 | 25.83M |
| December 31, 2012 | 28.21M |
| December 31, 2011 | 28.65M |
| December 31, 2010 | 29.65M |
| December 31, 2009 | 31.84M |
| Date | Value |
|---|---|
| December 31, 2008 | 33.11M |
| December 31, 2007 | 30.40M |
| December 31, 2006 | 30.72M |
| December 31, 2005 | 25.47M |
| December 31, 2004 | 20.20M |
| December 31, 2003 | 17.31M |
| December 31, 2002 | 16.09M |
| December 31, 2001 | 14.83M |
| December 31, 2000 | 14.87M |
| December 31, 1999 | 12.10M |
| December 31, 1998 | 12.00M |
| December 31, 1997 | 3.00M |
| December 31, 1996 | 3.00M |
| December 31, 1995 | 2.80M |
| December 31, 1994 | 2.40M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
40.47M
Minimum
2020
52.60M
Maximum
2023
45.85M
Average
45.46M
Median
2019
Research and Development Expense (Annual) Benchmarks
| SI-BONE Inc | 15.03M |
| Inari Medical Inc | 87.53M |
| Stereotaxis Inc | 10.27M |
| Electromed Inc | 0.916M |
| Myomo Inc | 2.636M |